CIVCO Medical Instruments Co., Inc., headquartered in the United States, is a leading provider of innovative medical solutions, specialising in ultrasound and radiation oncology. Founded in 1981, the company has established a strong presence in major operational regions across North America and Europe, delivering high-quality products that enhance patient care and clinical outcomes. CIVCO's core offerings include ultrasound transducer covers, positioning devices, and radiation therapy products, all designed with a focus on safety and efficiency. Their commitment to quality and innovation has positioned them as a trusted partner in the healthcare industry, recognised for their contributions to improving diagnostic and treatment processes. With a history of key milestones, CIVCO continues to set the standard for excellence in medical instrumentation.
How does CIVCO Medical Instruments Co., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CIVCO Medical Instruments Co., Inc.'s score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CIVCO Medical Instruments Co., Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Roper Technologies, Inc., and any climate commitments or emissions data would be inherited from this parent organisation. CIVCO's climate initiatives and reduction targets are not explicitly outlined, indicating a potential area for development in their sustainability strategy. However, as part of Roper Technologies, Inc., CIVCO may align with broader corporate sustainability goals and initiatives, including those related to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are cascaded from Roper Technologies. As of now, without specific emissions data or reduction targets, it is unclear how CIVCO Medical Instruments Co., Inc. is addressing its carbon footprint or contributing to climate action. The company may benefit from establishing clear climate commitments and measurable targets to enhance its sustainability profile in the medical instruments industry.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,810,470 | 0,000,000 | 0,000,000 | 
| Scope 2 | 21,543,820 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | 000,000,000 | 000,000,000 | 
CIVCO Medical Instruments Co., Inc.'s Scope 3 emissions, which increased by 2% last year and increased by approximately 2% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 49% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CIVCO Medical Instruments Co., Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.